BioNTech (BNTX) News Headlines

▮ More

Date

Headline

10/21/2021 7:21:37 AM Pfizer : Phase 3 Trial Data Shows 95.6% Efficacy In COVID-19 Vaccine Booster Dose

10/21/2021 6:47:51 AM Pfizer And BioNTech Say Phase 3 Trial Data Shows High Efficacy Of Booster Dose Of Their COVID-19 Vaccine

10/7/2021 10:26:52 AM Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine In Children 5 - 11

10/7/2021 9:52:58 AM Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine For Children 5 To Below 12

10/4/2021 11:35:59 PM EMA Committee Recommends Pfizer, Moderna COVID-19 Booster Doses

10/1/2021 3:27:08 AM BioNTech Reports Initiation Of Phase 2 Trial With MRNA Cancer Vaccine Candidate

10/1/2021 3:05:36 AM BioNTech Doses First Patient In Phase 2 Trial Of BNT122 In Colorectal Cancer Patients

9/28/2021 7:21:30 AM Pfizer, BioNTech Submit Positive Data From COVID-19 Vaccine Trial In 5 To <12 Years To FDA

9/28/2021 6:49:57 AM Pfizer, BioNTech Submit Initial Data To FDA From Phase 2/3 Trial Trial Of COVID-19 Vaccine In Children 5 To <12 Years

9/24/2021 6:38:01 AM CDC Advisers Recommend Pfizer Covid-19 Booster Doses For Certain Adults

9/22/2021 10:26:05 PM FDA Authorizes Pfizer COVID-19 Booster Shots For Older People And High-risk Workers

9/22/2021 6:28:44 AM Pfizer, BioNTech In Deal With U.S. To Provide 500 Mln More COVID-19 Vaccine Doses For Donation

9/22/2021 6:06:12 AM Pfizer, BioNTech Expand Collaboration With U.S. To Provide 500 Mln Addl COVID-19 Vaccine Doses

9/20/2021 7:21:55 AM Pfizer Announces Positive Results From Pivotal Trial Of COVID-19 Vaccine In Children 5 - 11 Yrs

9/20/2021 6:53:25 AM Pfizer, BioNTech Announce Positive Topline Results From Phase 2/3 Trial Of COVID-19 Vaccine In Children 5- 11 Yrs

9/15/2021 5:36:52 PM Pfizer Cites 95% Efficacy In Third Vaccine Shots; FDA Staff Skeptical

8/30/2021 11:07:32 PM CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine

8/26/2021 7:30:42 AM Pfizer, BioNTech In Deal With Brazil's Eurofarma To Manufacture COVID-19 Vaccine For Latin America

8/26/2021 6:51:03 AM Pfizer, BioNTech Ink LoI With Eurofarma Laboratrios To Manufacture COVID-19 Vaccine Doses COMIRNATY For Latin America

8/25/2021 12:14:46 PM Pfizer & BioNTech Initiate Rolling Submission Of Supplemental Biologics License Application To FDA

Biontech (BNTX)